Full-time · Global
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is redefining the transplant process by developing next-generation cell therapies with the goal of providing significantly better survival rates with dramatically fewer risks. With our purified, high-precision investigational cell therapies we hope to not only replace patients' blood and immune systems with healthy ones, but also restore their lives.
In this one-year assignment, with possibility for extension, we are looking for recent Ph.D graduates to lead projects focused on studying the fundamental biology of regulatory T cells (Tregs) and their role in immune regulation following adoptive transfer.
Key responsibilities include:
Required Qualifications: